Alpha Teknova (NASDAQ:TKNO) Issues Earnings Results

Alpha Teknova (NASDAQ:TKNO) released its quarterly earnings data on Wednesday. The company reported ($0.06) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.01, FiscalAI reports. Alpha Teknova had a negative return on equity of 24.94% and a negative net margin of 38.37%. The company had revenue of $12.70 million for the quarter, compared to analyst estimates of $11.71 million.

Alpha Teknova Trading Up 0.4%

NASDAQ TKNO traded up $0.03 during trading on Wednesday, hitting $7.37. The stock had a trading volume of 372,092 shares, compared to its average volume of 259,287. The company has a quick ratio of 3.48, a current ratio of 4.49 and a debt-to-equity ratio of 0.21. The company has a market capitalization of $395.77 million, a PE ratio of -23.77 and a beta of 0.96. The firm has a 50 day moving average price of $7.71 and a 200 day moving average price of $4.92. Alpha Teknova has a twelve month low of $1.91 and a twelve month high of $9.48.

Analyst Ratings Changes

Several research firms recently issued reports on TKNO. Zacks Research upgraded shares of Alpha Teknova to a “hold” rating in a research report on Thursday, August 6th. Roth Capital initiated coverage on shares of Alpha Teknova in a report on Wednesday, August 5th. They set a “buy” rating and a $7.00 price target for the company. Wall Street Zen raised Alpha Teknova from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. BTIG Research upgraded Alpha Teknova from a “neutral” rating to a “buy” rating and set a $8.00 target price on the stock in a research report on Tuesday, August 11th. Finally, Weiss Ratings cut shares of Alpha Teknova from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Tuesday, August 11th. Four equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat.com, Alpha Teknova presently has a consensus rating of “Moderate Buy” and a consensus target price of $8.75.

Alpha Teknova Company Profile

Alpha Teknova, Inc is a life sciences company that develops and manufactures critical reagents and other products used in biomedical research, biopharmaceutical development and advanced therapies. The company provides laboratory and production materials designed to support applications including cell and gene therapy, molecular diagnostics, next-generation sequencing, vaccine development and pharmaceutical manufacturing.

Its offerings include research-use-only and current Good Manufacturing Practice (cGMP) reagents, buffers, media and other custom-formulated solutions.